Psychosomatický přístup k nemocnému v ambulanci dermatovenerologa, ano či ne?

doc. MUDr. Růžena Pánková, CSc.

Dermatol. praxi. 2018;12(1):3  

Demodicosis

MUDr. Zuzana Nevoralová, Ph.D.

Dermatol. praxi. 2018;12(1):7-10 | DOI: 10.36290/der.2018.002  

Demodex mites are an integral part of human microbiom mostly beeing only harmless bystanders. Under certain cimcurstancesthey can cause mild to severe skin involvement called demodicosis. Primary demodicosis is an illness sui generis. Secondary demodicosisis usually connected with some form of organism´attenuation. Lesions are present mostly on a face, eye lids and in earcanals. For setting a diagnosis mostly only anamnesis and clinical checkup are enough. In unclear cases a microscope investigation,exceptionally a histopathological verification are necessary. For a therapy of demodicosis local and peroral treatments can beused. Basic local treatments...

Hand eczema

MUDr. Marta Pobijaková

Dermatol. praxi. 2018;12(1):12-16 | DOI: 10.36290/der.2018.003  

Hand eczema is a common chronically relapsing and difficult to treat dermatosis, affecting most of the individuals. It is a diseasewith a significant psychosocial impact on individuals and society in general. Targeted treatment are topical corticosteroids andimmunomodulators, important is also prevention, which consists of protecting the skin from irritation exogenous factors andregular care to restore the protective epidermal skin barrier.

Infrared thermography in diagnosis of Raynaud’s phenomenon – 2nd part

MUDr. Jan Šternberský, Mgr. Jana Zapletalová, Dr.

Dermatol. praxi. 2018;12(1):17-19 | DOI: 10.36290/der.2018.004  

The following second part of the article is aimed on practical part of the infrared thermography investigation, on its results andanalysis of the epidemiologic data of the patient with disorders of the acral blood circulation.

Topical therapy of acne vulgaris

MUDr. Kateřina Macháčková

Dermatol. praxi. 2018;12(1):20-24 | DOI: 10.36290/der.2018.005  

Acne vulgaris is a very common skin problem in young population. Its social impact is very seriousThe pillar of acne treatment istopical therapy, patients with severe forms of acne are indicated for the use of systemic treatment. Some methods of correctivedermatology are presented.

dermatomykózy, diagnóza, léčba

MUDr. Jarmila Čelakovská, Ph.D.

Dermatol. praxi. 2018;12(1):26-30  

The clinical diagnosis of mycotic affection of the skin is important part of daily work of general practicioner. This article gives thereview of diagnosis and prevention of mycological affection of the skin. There is given the review of different mycotic skin, nailsand scalp affections. The pictures show the skin findings.

Current therapeutical options in primary cutaneous T-cell lymphomas

MUDr. Jiří Ettler, prof. MUDr. Petr Arenberger, DrSc., MBA, FCMA, MUDr. Jindřich Polívka

Dermatol. praxi. 2018;12(1):31-35 | DOI: 10.36290/der.2018.007  

Primary cutaneous lymphomas are a rare type of extranodal non-hodgkin lymphomas where malignant T-cell or B-cell infiltrate theskin. Primary cutaneous T-cell lymphomas account for approximately three quarters of primary cutaneous lymphomas. Most patientswith primary cutaneous T-cell lymphoma are diagnosed in the early stage of the disease with. generally indolent clinical course.However, cases with aggresive course and unfavourable prognosis are not rare. This review briefly summarizes current therapeuticalmethods and emphasizes the options available in the Czech Republic for management of primary cutanenous T-cell lymphomas.

Omalizumab in the long-term management of severe chronic spontaneous urticaria – clinical experience

MUDr. Olga Filipovská

Dermatol. praxi. 2018;12(1):36-39 | DOI: 10.36290/der.2018.034  

17 patients with severe chronic spontaneous urticaria (CSU) with UAS7 score ≥ 28, not responding to an increased dose of H1-antihistamines,have been treated with omalizumab in the department of Dermatology of Masaryk Hospital Ústí nad Labem in2015–2017. Most of the patients for the severity of their disease have also been treated with corticosteroids for the long term,some patients have received cyclosporin A, methotrexate, montelukast, azathioprine. Treatment with omalizumab was successfulwith all the patients, 40% of patients achieving complete remission at 12 weeks of therapy. With all the patients, after initiation oftreatment with...

Acute generalised exantematous pustulosis

MUDr. Alena Stumpfová

Dermatol. praxi. 2018;12(1):40-42 | DOI: 10.36290/der.2018.035  

Acute generalised exantematous pustulosis (AGEP) is a rare, severe skin condition characterised by acute onset of sterile pustules.It is triggered mainly by new medication and resolves approximately 2 weeks after its withdrawal. It seems to be a connectionbetween mutation of interleukin 36 antagonist receptor (IL-36Ra) and development of generalised pustular eruption after intakeof new medication in some cases (1). This case reports AGEP caused by solifenacin. It took us longer time to set the right diagnosisas in the beginning the clinical features were not quite clear and, moreover, the onset of the symptoms was slower. Also therewas no specific...

Over-the-counter drugs against hair loss

Mgr. Markéta Peřinová

Dermatol. praxi. 2018;12(1):43-46 | DOI: 10.36290/der.2018.036  

Hair loss is one of the frequent reasons why patients come to the pharmacy and try to solve their problems by self-treatment.This paper offers an overview of over-the-counter drugs and medicinal substances against hair loss which exist either in oral ortopical route of administration. Although a wide range of products is available at the market only a few of them include registereddrugs. They are usually food supplements and cosmetic products. Most medical substances lack the proof of efficiency. The onlyexception is minoxidil but its effect disappears after 3 to 4 months from the end of the application. Other used substances includecaffeine, vitamins,...

Některé poznatky z 26. kongresu Evropské akademie dermatovenerologie (EADV) v Ženevě v roce 2017 – fotodermatologie

doc. MUDr. Karel Ettler, CSc.

Dermatol. praxi. 2018;12(1):50-51  

World Psoriasis Happiness Report – Celosvětová zpráva o spokojenosti osob s psoriázou

Dermatol. praxi. 2018;12(1):47-78